A Double-Blind Study in Healthy Volunteers to Assess the Effect of E7080 on the QTc Interval

Clinical trial NCT01525394 · COMPLETED

Trial details

NCT number: NCT01525394
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Solid Tumors Lymphomas

Start date: 2010-12-01
Primary completion: 2011-08-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.